Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ORA Clinical Research and Development

ORA Clinical Research and Development is a full service contract research organization based in North Andover, MA, which was founded by Dr. Mark B. Abelson, MD, and is committed to the research and development of medical devices and drugs for the ophthalmic and topical pharmaceutical industry. Specializing in the field of ophthalmology, ORA has gathered the top professionals and researchers in this field over the past 30 years. Combining a unique, dynamic, and dedicated group of research professionals known for their ability to produce quality results in a timely and cost effective manner, ORA has become a leader in its field.Dr. Abelson and ORA have developed an internationally renowned reputation for their core expertise in clinical-regulatory strategy, clinical model, study design, and execution specifically for ophthalmic products. ORA has extensive experience in the areas of allergy, dry eye, glaucoma, and anti-infective and anti-inflammatory ophthalmic treatments. ORA has since taken its knowledge and expertise into similar fields, which has grown the business exponentially. Through extensive research in the areas of allergy and dry eye, ORA has been able to identify similarities in the function of the eye, skin, and nose. This research has allowed ORA to expand its areas of research while keeping the level of knowledge and expertise at the same level study sponsors expect.


Contact Details:
863 Turnpike St
North Andover
Massachusetts
01845
United States of America
Tel:(978) 685-8900
Fax:
Email:info@oraclinical.com
WWW:

www.oraclinical.com/




Loading...

Recent Publications by ORA Clinical Research and Development:

The effect of senofilcon A contact lenses compared to habitual contact lenses on ocular discomfort during exposure to a controlled adverse environment.
OBJECTIVE: Contact lens wear is often associated with signs and symptoms...
29th February, 2008
ORA Clinical Research and Development, North Andover, MA 01845, USA. Curr Med Res Opin. 2008 Feb;24(2):335-41.
DOI Direct Link
An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis.
BACKGROUND: Systemic antihistamines such as loratadine are efficacious in...
8th August, 2007
ORA Clinical Research and Development, North Andover, Massachusetts 01845, Clin Ther. 2007 Apr;29(4):611-6.
DOI Direct Link
Ocular allergy in pediatric practice.
Allergies occur frequently in all pediatric age groups, affecting up to...
3rd November, 2006
ORA Clinical Research and Development, North Andover, MA 01845, USA. Curr Allergy Asthma Rep. 2006 Jul;6(4):306-11.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1156 times since April 2007, the link to the organisation's website has been followed 250 times

Recent Search Terms used to find this page: ora ophthalmic | mark abelson md ora | ORA Clinical Research Development North Andover Massachusetts | oRA rESEARCH DEVELOPMENT | ora clinical research organisation | ora andover ma | ora clinical research and development | ora clinical andover | ora clinical in MA | ora clinical | .

Search for more companies in North Andover

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ORA Clinical Research and Development

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.